Literature DB >> 26513055

Risk of second primary breast cancer after radioactive iodine treatment in thyroid cancer: a systematic review and meta-analysis.

Yingjie Zhang1, Jun Liang, Hui Li, Hui Cong, Yansong Lin.   

Abstract

The aim of this study was to determine whether the risk of second primary breast cancer (SPBC) is increased in thyroid cancer patients treated with radioactive iodine (RAI). We searched the MEDLINE, EMBASE, and the Cochrane Library and Chinese database for studies that reported the risk of SPBC in thyroid cancer patients treated with RAI and patients not treated with RAI. Two independent reviewers screened citations and reviewed full-text papers. A meta-analysis was carried out using the Review Manager software. Six cohort studies (three from Europe, one from America, and two from east Asia) with 17,914 patients were included in this review. The relative risk of SPBC in thyroid cancer survivors treated with RAI was 0.61 (95% confidence interval 0.47-0.79) relative to thyroid cancer survivors not treated with RAI. The risk of SPBC in thyroid cancer survivors treated with RAI is not increased compared with thyroid cancer survivors not treated with RAI.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26513055     DOI： 10.1097/MNM.0000000000000419

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN： 0143-3636            Impact factor:   1.690


  11 in total

1.  Thyroid nodules coexisting with either cystic or solid breast nodules: a new clue for this association between nodules coming from ultrasonography.

Authors:  Alessandro Sindoni; Fausto Fama'; Antonio Rosano'; Claudio Scisca; Gianlorenzo Dionigi; Christian A Koch; Maria Gioffrè-Florio; Salvatore Benvenga
Journal:  Gland Surg       Date:  2017-12

2.  Influence of the first radioactive iodine ablation on peripheral complete blood count in patients with differentiated thyroid cancer.

Authors:  Tianpeng Hu; Zhaowei Meng; Guizhi Zhang; Qiang Jia; Jian Tan; Wei Zheng; Renfei Wang; Xue Li; Na Liu; Pingping Zhou; Arun Upadhyaya
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 3.  Review of the possible association between thyroid and breast carcinoma.

Authors:  Liangbo Dong; Jun Lu; Bangbo Zhao; Weibin Wang; Yupei Zhao
Journal:  World J Surg Oncol       Date:  2018-07-05       Impact factor: 2.754

4.  Association of Radioiodine for Differentiated Thyroid Cancer and Second Breast Cancer in Female Adolescent and Young Adult.

Authors:  Xianlan Zhao; Mingjing Chen; Xiaojing Qi; Haizhen Zhu; Guangrong Yang; Yi Guo; Qiang Dong; Qiao Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-28       Impact factor: 5.555

Review 5.  Thyroid Diseases and Breast Cancer.

Authors:  Enke Baldini; Augusto Lauro; Domenico Tripodi; Daniele Pironi; Maria Ida Amabile; Iulia Catalina Ferent; Eleonora Lori; Federica Gagliardi; Maria Irene Bellini; Flavio Forte; Patrizia Pacini; Vito Cantisani; Vito D'Andrea; Salvatore Sorrenti; Salvatore Ulisse
Journal:  J Pers Med       Date:  2022-01-25

Review 6.  Is Melanoma Progression Affected by Thyroid Diseases?

Authors:  Salvatore Ulisse; Enke Baldini; Daniele Pironi; Federica Gagliardi; Domenico Tripodi; Augusto Lauro; Sabino Carbotta; Danilo Tarroni; Matteo D'Armiento; Aldo Morrone; Flavio Forte; Flaminia Frattaroli; Severino Persechino; Teresa Odorisio; Vito D'Andrea; Eleonora Lori; Salvatore Sorrenti
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

Review 7.  Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey.

Authors:  Christoph Reiners; Rita Schneider; Tamara Platonova; Mikhail Fridman; Uwe Malzahn; Uwe Mäder; Alexis Vrachimis; Tatiana Bogdanova; Jolanta Krajewska; Rossella Elisei; Fernanda Vaisman; Jasna Mihailovic; Gracinda Costa; Valentina Drozd
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-10       Impact factor: 5.555

8.  Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.

Authors:  Shuting Li; Jiao Yang; Yanwei Shen; Xiaoai Zhao; Lingxiao Zhang; Biyuan Wang; Pan Li; Yunmei Wang; Min Yi; Jin Yang
Journal:  BMC Public Health       Date:  2019-11-29       Impact factor: 3.295

9.  Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden.

Authors:  Bence Bakos; András Kiss; Kristóf Árvai; Ádám Tabák; Péter Lakatos; Balázs Szili; Barbara Deák-Kocsis; Bálint Tobiás; Zsuzsanna Putz; Richárd Ármós; Bernadett Balla; János Kósa; Magdolna Dank; Zsuzsanna Valkusz; István Takács
Journal:  BMC Cancer       Date:  2021-06-15       Impact factor: 4.430

10.  Assessment of Long-Term Hematologic Effects in Differentiated Thyroid Cancer Patients Treated with Radioactive Iodine

Authors:  Bircan Sönmez; Özlen Bektaş; Nergiz Erkut; Mehmet Sönmez
Journal:  Turk J Haematol       Date:  2021-03-22       Impact factor: 1.831
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.